52 participants
A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-08-21
- Start Date:
- 2019-01-30
- Completion:
- 2021-06-08
Conditions
- Giant Cell Arteritis
Interventions
- DRUG